03:54 (GMT +7) - Friday 23/10/2020


Abbott introduces breakthrough infant formula

Released at: 09:21, 05/06/2018

Abbott introduces breakthrough infant formula

Photo: Viet Tuan

HMO, a special immune boosting ingredient previously found only in breast milk, is now part of Abbott's Similac infant formula.

by Nghi Do

Abbott announced the launch of its most innovative infant formula, Similac Eye-Q Plus with HMO (Human Milk Oligosaccharides), in Vietnam on June 4 in Hanoi; a groundbreaking development in infant nutrition science.

Breast milk is considered the gold standard for feeding infants and breastfed babies tend to have stronger immune systems compared to those who are fed formula. This is due in part to the unique immune-nourishing qualities of HMOs, which are the most abundant solid component of breast milk after fat and carbohydrate (lactose), and research has shown this special ingredient plays a fundamental role in a baby’s digestive health and immunity.

Until recently, HMOs have only been present in breast milk. However, in the biggest breakthrough in infant formula research in the last decade, Abbott has now included the most prevalent HMO in most mothers’ milk, 2’-fucosyllactose (2’-FL) HMO in its Similac formula.

“The discovery of HMOs and the addition to baby formula marks an unprecedented leap forward in infant nutrition with potentially significant immunity benefits,” said Dr. Barbara Marriage, Global Science Lead, Pediatric Specialty Nutrition, Science and Medical Affairs at Abbott. “The inclusion of FL HMO in infant formula gives parents the confidence that their baby is able to get some of the nourishment they need to support a healthy immune system, even if they aren’t able to breastfeed.”

Abbott spent more than 15 years researching HMOs and gut health and fully understands their role in supporting the development of a baby’s immune system during the critical first years of life, according to Mr. Douglas Kuo, General Manager of Abbott Vietnam.

Research published by Abbott scientists in the Journal of Nutrition studied more than 200 babies to compare the differences between breastfeed babies and those who had been given a formula with 2’-FL HMO. The peer-reviewed study found the formula can help close the gap in immune function between formula and breastfeed babies.

Similac is the first formula to come on the market globally with 2’-FL HMO. The products have been available at traditional and online channels throughout Vietnam since June 2.

User comment (0)

Send comment